|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
animals
humans
|
|
gptkbp:alternativeName
|
lockjaw
|
|
gptkbp:category
|
gptkb:neurological_disorder
gptkb:disease
|
|
gptkbp:causedBy
|
gptkb:Clostridium_tetani
|
|
gptkbp:commonIn
|
developing countries
|
|
gptkbp:complication
|
gptkb:pneumonia
respiratory failure
bone fractures
|
|
gptkbp:firstDescribed
|
gptkb:19th_century
|
|
gptkbp:ICD-10_code
|
A35
|
|
gptkbp:incubationPeriod
|
3 to 21 days
|
|
gptkbp:mortalityRate
|
high without treatment
|
|
gptkbp:prevention
|
tetanus vaccine
|
|
gptkbp:rareIn
|
countries with high vaccination rates
|
|
gptkbp:symptom
|
fever
muscle stiffness
difficulty swallowing
high blood pressure
sweating
rapid heart rate
muscle spasms
lockjaw
|
|
gptkbp:transmission
|
wound contamination
|
|
gptkbp:transmittedBy
|
person-to-person contact
|
|
gptkbp:treatment
|
gptkb:antitoxin
antibiotics
wound care
muscle relaxants
|
|
gptkbp:vaccineType
|
toxoid vaccine
|
|
gptkbp:WHOClassification
|
vaccine-preventable disease
|
|
gptkbp:bfsParent
|
gptkb:Vaccination
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tetanus
|